MARÍA JOSÉ
SERRANO FERNÁNDEZ
Researcher in the period 2022-2023
JOSÉ ANTONIO
LORENTE ACOSTA
CATEDRÁTICO DE UNIVERSIDAD
Publications by the researcher in collaboration with JOSÉ ANTONIO LORENTE ACOSTA (44)
2023
2022
-
A Novel, Quick, and Reliable Smartphone-Based Method for Serum PSA Quantification: Original Design of a Portable Microfluidic Immunosensor-Based System
Cancers, Vol. 14, Núm. 18
-
Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior
Theranostics, Vol. 12, Núm. 5, pp. 2150-2161
-
Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception
Frontiers in Molecular Biosciences, Vol. 9
-
Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective
Molecular Genetics and Genomics, Vol. 297, Núm. 3, pp. 859-871
2021
-
Cross‐resistance to abiraterone and enzalutamide in castration resistance prostate cancer cellular models is mediated by ar transcriptional reactivation
Cancers, Vol. 13, Núm. 6, pp. 1-21
-
Deep phenotypic characterisation of CTCs by combination of microfluidic isolation (Isoflux) and imaging flow cytometry (imagestream)
Cancers, Vol. 13, Núm. 24
-
Sandwich-Type Electrochemical Paper-Based Immunosensor for Claudin 7 and CD81 Dual Determination on Extracellular Vesicles from Breast Cancer Patients
Analytical Chemistry, Vol. 93, Núm. 2, pp. 1143-1153
2020
-
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)
Critical Reviews in Oncology/Hematology, Vol. 151
-
Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))
Critical Reviews in Oncology/Hematology
-
Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients
Scientific Reports, Vol. 10, Núm. 1
-
From precision medicine to imprecision medicine through limited diagnostic ability to detect low allelic frequency mutations
Translational Lung Cancer Research, Vol. 9, Núm. 2, pp. 180-183
-
Precision prevention and cancer interception: The new challenges of liquid biopsy
Cancer Discovery, Vol. 10, Núm. 11, pp. 1635-1644
-
Strategies for isolation and phenotypic, genetic, and functional characterization of circulating tumor cells
Cancers
-
The polemic diagnostic role of TP53 mutations in liquid biopsies from breast, colon and lung cancers
Cancers, Vol. 12, Núm. 11, pp. 1-17
2019
-
Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents
Cells, Vol. 8, Núm. 11
-
EGFR detection in extracellular vesicles of breast cancer patients through immunosensor based on silica-chitosan nanoplatform
Talanta, Vol. 194, pp. 243-252
-
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy
Breast Cancer Research, Vol. 21, Núm. 1
-
Liquid biopsy beyond of cancer: Circulating pulmonary cells as biomarkers of COPD aggressivity
Critical Reviews in Oncology/Hematology, Vol. 136, pp. 31-36
-
Post-surgery circulating tumor cells and AXL overexpression as new poor prognostic biomarkers in resected lung adenocarcinoma
Cancers, Vol. 11, Núm. 11